Efficacy and safety of rituximab in the treatment of pediatric myasthenia gravis
Objective: To evaluate the efficacy and safety of rituximab in pediatric myasthenia gravis (MG). Methods: Case series study. The clinical manifestations, laboratory tests, treatment plans and prognosis of 27 pediatric MG patients treated with rituximab from June 2013 to June 2023 at Children's...
Ausführliche Beschreibung
Bibliographische Detailangaben
Veröffentlicht in: | Zhonghua er ke za zhi = Chinese journal of pediatrics. - 1960. - 62(2024), 11 vom: 02. Nov., Seite 1050-1055
|
1. Verfasser: |
Tong, Y N
(VerfasserIn) |
Weitere Verfasser: |
Wei, C J,
Yang, X L,
Ji, T Y,
Zhang, Y,
Wu, Y,
Chang, X Z,
Bao, X H,
Jiang, Y W,
Xiong, H,
Zhang, Y H |
Format: | Online-Aufsatz
|
Sprache: | Chinese |
Veröffentlicht: |
2024
|
Zugriff auf das übergeordnete Werk: | Zhonghua er ke za zhi = Chinese journal of pediatrics
|
Schlagworte: | English Abstract
Journal Article
Rituximab
4F4X42SYQ6
Immunosuppressive Agents
Autoantibodies
Receptors, Cholinergic
Cyclosporine
83HN0GTJ6D
Azathioprine
MRK240IY2L |